Thanks to private funding, 100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed more than $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2015 | 2014 |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2001 Research Grants

Argiris Efstratiadis, M.D., Ph.D.
Development of a Mouse Model of Pancreatic Cancer
Columbia University

Anirban Maitra, MBBS
Genetic Basis of Familial Pancreatic Cancer: A Novel Approach Using Whole Genome Conversion and High-Throughput Oligonucleotide Microarrays
Johns Hopkins University 

Raul Urrutia, M.D.
Role of Novel Sp1-like Proteins in the Transcriptional Silencing Carcinogen-activating Enzymes in Exocrine Pancreatic Cells
Mayo Clinic at Rochester

Albert Koong, M.D., Ph.D.
Selective Modulators of Protein Kinase C Activity as a Novel Class of Hypoxia Cell Cytotoxins in Human Pancreatic Cancer
Stanford University

Anson W. Lowe, M.D.
Characterizing the Gene-expression Profile of Human Pancreatic Cancers
Stanford University 

Richard Bold, M.D.
Anti-apoptotic Signaling through the AKT Kinase in Pancreatic Cancer
University of California at Davis Cancer Center

Martin McMahon, Ph.D.
A Systematic, Genome-Wide Analysis of Gene Copy Number Alteration in Pancreatic Cancer Cells by Array CGH
University of California at San Francisco Comprehensive Cancer Center

Craig Logsdon, Ph.D.
The Role of ATDC in Radioresistance of Pancreatic Adenocarcinoma
University of Michigan

Michel Ouellette, Ph.D.
In-Vitro Models of Pancreatic Cancer Development
University of Nebraska Medical Center
Eppley Cancer Research Institute

Adrienne D. Cox, Ph.D.
Functional Consequences of Oncogenically Mutated Kras in Pancreatic Cancer
University of North Carolina at Chapel Hill

Katherine Pogue-Geile, Ph.D.
Functional Identification of Pancreatic Tumor Suppressor Genes
University of Pittsburgh Cancer Institute

Ramesh K. Ramanathan, M.D.
Olivera Finn, Ph.D.
Phase I/II Study of a MUC-1 Pulsed Dendritic Cell Vaccine In Resected Pancreatic and Biliary Cancers
University of Pittsburgh Cancer Institute

Lee Ellis, M.D.
Role of Neuropilin-1 in Pancreatic Cancer Growth and Angiogenesis
University of Texas M.D. Anderson Cancer Center

415 Crossways Park Drive, Suite D, Woodbury, NY 11797
Toll Free: 1-866-789-1000 P: 516-737-1550 F: 516-584-6265


2015 website development and design sponsored by Celgene